Literature DB >> 31444556

Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.

Kyoko Motomura1, Hiroyuki Yamashita2, Saeko Yamada1, Yuko Takahashi1, Hiroshi Kaneko1.   

Abstract

The objective of this study was to identify factors predictive of malignancy in patients with polymyositis (PM) and dermatomyositis (DM) in Japan. We conducted a retrospective study of PM and DM patients who were admitted to our hospital between January 1992 and September 2017. Among 134 patients, 29 (21.6%) were diagnosed with cancer in the 3 years prior to and 3 years after the initial diagnosis of PM or DM. According to multivariate analyses, male sex [odds ratio (OR) = 3.65, p = 0.03], old age (OR = 1.05, p = 0.02), and a past history of diabetes mellitus (OR = 10.4, p = 0.005) were associated with an increased risk of malignancy. The absence of interstitial lung disease (ILD) (OR = 0.25, p = 0.03) was also associated with an increased risk of malignancy. Diabetes mellitus was observed in 28.6% of PM and DM patients with malignancy, but in only 7.3% of those with malignancy. Survival was significantly lower in patients with malignancy than in those without malignancy (p < 0.001). Independent factors associated with malignancies in patients with PM or DM were male sex, old age, the absence of ILD, and, especially, a past history of diabetes mellitus.

Entities:  

Keywords:  Dermatomyositis; Diabetes mellitus; Malignancy; Polymyositis

Mesh:

Year:  2019        PMID: 31444556     DOI: 10.1007/s00296-019-04428-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

Authors:  I Marie; E Hachulla; P Y Hatron; M F Hellot; H Levesque; B Devulder; H Courtois
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

3.  Prognosis and mortality of polymyositis and dermatomyositis patients.

Authors:  A Airio; H Kautiainen; M Hakala
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

4.  Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.

Authors:  R Buchbinder; A Forbes; S Hall; X Dennett; G Giles
Journal:  Ann Intern Med       Date:  2001-06-19       Impact factor: 25.391

5.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

6.  Survival, mortality and causes of death in inflammatory myopathies.

Authors:  Carmen Torres; Rebeca Belmonte; Loreto Carmona; F Javier Gómez-Reino; María Galindo; Belén Ramos; Ana Cabello; Patricia E Carreira
Journal:  Autoimmunity       Date:  2006-05       Impact factor: 2.815

7.  Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study.

Authors:  Nobuo Wakata; Teruyuki Kurihara; Eizo Saito; Masao Kinoshita
Journal:  Int J Dermatol       Date:  2002-11       Impact factor: 2.736

8.  Cancer-associated myositis: clinical features and prognostic signs.

Authors:  Andrea Ponyi; Tamás Constantin; Miklós Garami; Csilla András; Béla Tállai; Andrea Váncsa; Lajos Gergely; Katalin Dankó
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

9.  Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.

Authors:  Agnès Sparsa; Eric Liozon; François Herrmann; Kim Ly; Valérie Lebrun; Pascale Soria; Véronique Loustaud-Ratti; Marie-Laure Bouyssou-Gauthier; Serge Boulinguez; Christophe Bédane; Marie-Odile Jauberteau; Elisabeth Vidal; Jean-Marie Bonnetblanc
Journal:  Arch Dermatol       Date:  2002-07

10.  Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.

Authors:  D Stockton; V R Doherty; D H Brewster
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

View more
  4 in total

Review 1.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

2.  Advanced lung adenocarcinoma detected by choroidal metastasis in a patient with amyopathic dermatomyositis: A case report.

Authors:  Takako Kawaguchi; Kei Yamasaki; Tatsuya Shingu; Taiki Manabe; Satoko Koga; Sho Naruse; Moe Kidogawa; Fuki Ujimiya; Chinatsu Nishida; Kazuhiro Yatera
Journal:  Thorac Cancer       Date:  2022-04-22       Impact factor: 3.223

3.  Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.

Authors:  Hideyuki Minagawa; Taketo Kawai; Akihiko Matsumoto; Katsuhiro Makino; Yusuke Sato; Kenji Nagasaka; Masami Tokura; Nao Tanaka; Eisaku Ito; Yuta Yamada; Masaki Nakamura; Daisuke Yamada; Motofumi Suzuki; Takashi Murata; Haruki Kume
Journal:  BMC Urol       Date:  2021-01-07       Impact factor: 2.264

4.  Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.

Authors:  Jung-Lung Hsu; Ming-Feng Liao; Chun-Che Chu; Hung-Chou Kuo; Rong-Kuo Lyu; Hong-Shiu Chang; Chiung-Mei Chen; Yih-Ru Wu; Kuo-Hsuan Chang; Yi-Ching Weng; Chun-Wei Chang; Hsing-I Chiang; Chih-Kuang Cheng; Pai-Wei Lee; Chin-Chang Huang; Long-Sun Ro
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.